Manufacturer: Maxtreme Substance: Liothyronine (T3) Pack: 25mcg (50 pills)
T3-Max-25 is commonly associated with the synthetic brand of thyroid hormone Liothyronin sodium. The drug is an excellent copy of the naturally produced thyroid hormone triiodothyronine or, as it is commonly called, the hormone T3.
While synthetic T3-Max-25 has been available since the 1950s, thyroid hormones, including T3, have been used in medicine since the 1890s. Early plans for treating the thyroid gland included animal biological extracts that contained the pure forms of the hormones T3 and T4. The extracted thyroid hormones have proven to be very useful for therapeutic purposes, especially for the treatment of hypothyroidism.
Hypothyroidism is a condition in which the thyroid does not produce enough hormones, which can lead to weight gain, loss of energy, hair loss, as well as changes in the appearance and texture of the skin. Taking T3-Max-25, a synthetic model of the hormone T3, has proven to be safer and more healthful for such treatment.
The thyroid hormone, the left-handed isomer of triiodothyrosine, replenishes the deficiency of thyroid hormones.
Increases the need for tissues in oxygen, stimulates their growth and differentiation, increases the level of basal metabolism (proteins, fats and carbohydrates).
In small doses, the drug is anabolic, and in large doses, the catabolic effect. Treatment with lyotyronine inhibits the production of TSH. Strengthens energy processes, positively affects the state of the nervous system, CCC, liver and kidneys. The maximum pharmacological effect of Lyotyronin develops in 2-3 days.
Allergic reactions to components of Lyotyronin, progression of heart failure and stenocardia.
Symptoms: thyrotoxicosis (palpitations, arrhythmias (including tachycardia), increased sweating, anxiety, irritability, weight loss, increased appetite, diarrhea, tremor, fever, vomiting, headache, dysmenorrhea).
Treatment of an overdose of Lyotyronine: induction of vomiting, activated charcoal, symptomatic treatment.
Not suitable for long-term therapy. When appointing Liotironin with indirect anticoagulants and oral hypoglycemic drugs, it is necessary to control the time of blood coagulation and the level of glycemia.